Page 5 - Ping Chua News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Cost-sharing still substantial for some using nonbranded auto-injectors, such as those enrolled in high-deductible health plans.

FRIDAY, July 22, 2022 (HealthDay News) -- Out-of-pocket spending for epinephrine auto-injectors decreased among privately insured patients in 2017, coinciding with availability of lower-priced nonbranded products, according to a report published online July 11 in the Journal of General Internal Medicine. Kao-Ping Chua, M.D., Ph.D., from University of Michigan in Ann Arbor, and Rena M.

People with severe allergies now have more choices for which epinephrine auto-injector to carry in case they suffer a life-threatening attack, and most pay less for it than they did when the EpiPen was the primary option, a new study shows.

A small tweak to hospitals' prescribing systems might make a big difference in reducing risk from leftover opioid pain medication, while still making sure surgery patients get relief from their post-operation pain, a new study suggests.

Millions of Americans have needed hospitalization for COVID-19 since the pandemic began, including hundreds of thousands in the recent Omicron surge.